• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见良性胸腔积液的病因和处理。

Causes and management of common benign pleural effusions.

机构信息

Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Hospital avenue Perth, Western Australia 6009, Australia.

出版信息

Thorac Surg Clin. 2013 Feb;23(1):25-42, v-vi. doi: 10.1016/j.thorsurg.2012.10.004.

DOI:10.1016/j.thorsurg.2012.10.004
PMID:23206715
Abstract

Benign pleural effusions are twice as common as malignant effusions and have diverse causes and manifestations, which often makes them a diagnostic challenge. Differentiating effusions as a transudate or exudate is the first, and often helpful, step in directing investigations for diagnosis and management. Congestive heart failure and hepatic hydrothorax are the commonest causes for a transudative effusion. Commonly exudative effusions are caused by infections or may be secondary to pulmonary embolism, drugs, collagen vascular diseases, or may follow cardiac surgery. This article gives an overview of the causes and management of common benign pleural effusions.

摘要

良性胸腔积液的发生率是恶性胸腔积液的两倍,其病因和临床表现多种多样,这常常使它们成为诊断上的挑战。将胸腔积液分为漏出液或渗出液是诊断和管理中首先进行的、通常也是很有帮助的步骤。充血性心力衰竭和肝性胸水是漏出液最常见的原因。常见的渗出液是由感染引起的,也可能继发于肺栓塞、药物、胶原血管疾病,或可能在心外科手术后发生。本文概述了常见良性胸腔积液的病因和处理方法。

相似文献

1
Causes and management of common benign pleural effusions.常见良性胸腔积液的病因和处理。
Thorac Surg Clin. 2013 Feb;23(1):25-42, v-vi. doi: 10.1016/j.thorsurg.2012.10.004.
2
Pleural effusions.胸腔积液。
Med Clin North Am. 2011 Nov;95(6):1055-70. doi: 10.1016/j.mcna.2011.08.005. Epub 2011 Sep 25.
3
Transudative pleural effusions.漏出性胸腔积液
Clin Chest Med. 1985 Mar;6(1):49-54.
4
Hepatic Hydrothorax and Congestive Heart Failure Induced Pleural Effusion.肝性胸水和充血性心力衰竭性胸腔积液。
Clin Chest Med. 2021 Dec;42(4):625-635. doi: 10.1016/j.ccm.2021.07.005.
5
Transudative effusions.漏出液
Eur Respir J. 1997 Mar;10(3):714-8.
6
[Diagnostic value of pleural fluid cytologic examination].[胸腔积液细胞学检查的诊断价值]
Medicina (Kaunas). 2002;38(12):1171-8.
7
Diagnostic approach to pleural effusion in adults.成人胸腔积液的诊断方法
Am Fam Physician. 2006 Apr 1;73(7):1211-20.
8
Decision making and algorithm for the management of pleural effusions.胸腔积液处理的决策和算法。
Thorac Surg Clin. 2013 Feb;23(1):11-6, v. doi: 10.1016/j.thorsurg.2012.10.009.
9
Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.血清和胸腔积液N末端B型利钠肽原浓度在胸腔积液鉴别诊断中的应用
Tuberk Toraks. 2011;59(1):1-7.
10
Cytologically proved malignant pleural effusions: distribution of transudates and exudates.经细胞学证实的恶性胸腔积液:漏出液与渗出液的分布情况
Chest. 1998 May;113(5):1302-4. doi: 10.1378/chest.113.5.1302.

引用本文的文献

1
Diagnostic accuracy of SHOX-2 methylation for malignant pleural effusion: a systematic review and meta-analysis.SHOX-2甲基化检测对恶性胸腔积液的诊断准确性:一项系统评价和荟萃分析
Transl Cancer Res. 2025 Aug 31;14(8):4955-4964. doi: 10.21037/tcr-2025-686. Epub 2025 Aug 19.
2
Analysis of the clinical manifestations and diagnostic process of the pleural effusion associated with constrictive pericarditis.缩窄性心包炎相关胸腔积液的临床表现及诊断过程分析
Front Med (Lausanne). 2024 Nov 15;11:1419750. doi: 10.3389/fmed.2024.1419750. eCollection 2024.
3
Incidental Metastatic Lung Cancer in a Patient Being Treated for Community-Acquired Pneumonia: The Case for Lung Cancer Screening in Rural America.
一名正在接受社区获得性肺炎治疗的患者发生了偶然转移性肺癌:美国农村地区肺癌筛查的案例
Cureus. 2023 Apr 27;15(4):e38213. doi: 10.7759/cureus.38213. eCollection 2023 Apr.
4
Determination of efficacy and safety of zeolite as a new pleurodesis agent.确定沸石作为一种新型胸膜固定术药物的疗效和安全性。
Toxicol Rep. 2022 Sep 9;9:1754-1765. doi: 10.1016/j.toxrep.2022.09.003. eCollection 2022.
5
Lung Cancer: Spectral and Numerical Differentiation among Benign and Malignant Pleural Effusions Based on the Surface-Enhanced Raman Spectroscopy.肺癌:基于表面增强拉曼光谱的良恶性胸腔积液的光谱和数值鉴别
Biomedicines. 2022 Apr 25;10(5):993. doi: 10.3390/biomedicines10050993.
6
BCNU (Bis-chloroethylnitrosourea, Carmustine) Toxicity Presented as a Large Pleural Effusion 60 Days Post Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma.卡莫司汀(双氯乙基亚硝脲)毒性表现为非霍奇金淋巴瘤自体干细胞移植60天后出现大量胸腔积液。
Cureus. 2019 Feb 12;11(2):e4052. doi: 10.7759/cureus.4052.
7
Pleural transudate: pathophysiology during superior vena cava syndrome.胸腔漏出液:上腔静脉综合征时的病理生理学
ERJ Open Res. 2019 Feb 25;5(1). doi: 10.1183/23120541.00251-2018. eCollection 2019 Feb.
8
Malignant pleural mesothelioma presenting with remitting-relapsing pleural effusions: report of two cases.以缓解-复发型胸腔积液为表现的恶性胸膜间皮瘤:2例报告
Respirol Case Rep. 2018 Feb 23;6(3):e00306. doi: 10.1002/rcr2.306. eCollection 2018 Apr.
9
Diagnostic value of tumour markers in pleural effusions.胸腔积液肿瘤标志物的诊断价值。
Biochem Med (Zagreb). 2018 Feb 15;28(1):010706. doi: 10.11613/BM.2018.010706. Epub 2018 Jan 10.
10
Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.血管内皮生长因子及胸腔积液中的蛋白水平用于鉴别恶性与良性胸腔积液
Oncol Lett. 2017 Sep;14(3):3657-3662. doi: 10.3892/ol.2017.6631. Epub 2017 Jul 20.